Shari L. Caplan

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +10

Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury

Margaret F. Prescott, Wilbur K. Sawyer, JEAN VON LINDEN‐REED et al. · Annals of the New York Academy of Sciences · 1999 · 143 citations

Medicine, Cardiology, Pharmacology +14

Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes

Gregory R. Bebernitz, Valérie Beaulieu, Bethany A. Dale et al. · Journal of Medicinal Chemistry · 2009 · 91 citations

Life Sciences, Biochemistry, Pharmacology +17

Treatment of Type 2 Diabetes by Adenoviral-Mediated Overexpression of the Glucokinase Regulatory Protein

Eric D. Slosberg, Urvi J. Desai, Barbara Fanelli et al. · Diabetes · 2001 · 73 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +16

Catalytically important domains of rat carnitine palmitoyltransferase II as determined by site-directed mutagenesis and chemical modification. Evidence for a critical histidine residue.

Nicholas F. Brown, R.C. Anderson, Shari L. Caplan et al. · Journal of Biological Chemistry · 1994 · 68 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14